Foamix Pharmaceuticals Ltd. Other Research and Development Expense
Foamix Pharmaceuticals Ltd. reported Other Research and Development Expense of $1.02 million for the 12-month period ending 2015-12-31, per its 20-F filed 2016-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2016-03-02
| Period end | Other Research and Development Expense 12 month |
|---|---|
| 2015-12-31 | $1.02M 20-F · filed 2016-03-02 |
| 2014-12-31 | $266.00K 20-F · filed 2016-03-02 |
| 2013-12-31 | $311.00K 20-F · filed 2016-03-02 |
| 2012-12-31 | $468.00K 20-F · filed 2015-03-17 |